Nektar Therapeutics (NKTR): Price and Financial Metrics
Nektar Therapeutics (NKTR)
Today's Latest Price: $17.61 USD
Updated Sep 25 4:00pm
Add NKTR to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
NKTR Stock Summary
- Of note is the ratio of Nektar Therapeutics's sales and general administrative expense to its total operating expenses; only 8.83% of US stocks have a lower such ratio.
- NKTR's price/sales ratio is 19.39; that's higher than the P/S ratio of 92.54% of US stocks.
- With a year-over-year growth in debt of -54.74%, Nektar Therapeutics's debt growth rate surpasses only 4.94% of about US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Nektar Therapeutics are CLLS, ZYME, RGNX, PRQR, and APTX.
- NKTR's SEC filings can be seen here. And to visit Nektar Therapeutics's official web site, go to www.nektar.com.
NKTR Stock Price Chart Technical Analysis Charts
NKTR Price/Volume Stats
| Current price | $17.61 | 52-week high | $28.60 |
| Prev. close | $18.03 | 52-week low | $13.63 |
| Day low | $17.48 | Volume | 1,336,105 |
| Day high | $18.16 | Avg. volume | 1,440,606 |
| 50-day MA | $20.56 | Dividend yield | N/A |
| 200-day MA | $20.91 | Market Cap | 3.15B |
Nektar Therapeutics (NKTR) Company Bio
Nektar Therapeutics is a biopharmaceutical company, developing drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. Its product pipeline includes drug candidates in therapeutic areas comprising oncology, pain, anti-infectives, and immunology.
Loading social stream, please wait...